TARO Annual Accounts Payable
$44.66 M
-$23.82 M-34.78%
31 March 2024
Summary:
As of January 28, 2025, TARO annual accounts payable is $44.66 million, with the most recent change of -$23.82 million (-34.78%) on March 31, 2024. During the last 3 years, it has fallen by -$16.50 million (-26.98%).TARO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Quarterly Accounts Payable
$44.66 M
-$6.52 M-12.74%
31 March 2024
Summary:
As of January 28, 2025, TARO quarterly accounts payable is $44.66 million, with the most recent change of -$6.52 million (-12.74%) on March 31, 2024. Over the past year, it has dropped by -$6.52 million (-12.74%).TARO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.8% | -12.7% |
| 3 y3 years | -27.0% | -27.0% |
| 5 y5 years | +27.4% | +20.6% |
TARO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -68.4% | -84.6% |
Taro Pharmaceutical Industries Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $44.66 M(-34.8%) | $44.66 M(-12.7%) |
| Dec 2023 | - | $51.18 M(+18.9%) |
| Sept 2023 | - | $43.06 M(-27.5%) |
| June 2023 | - | $59.37 M(-13.3%) |
| Mar 2023 | $68.48 M(+0.4%) | $68.48 M(+11.6%) |
| Sept 2022 | - | $61.36 M(-17.0%) |
| June 2022 | - | $73.92 M(+8.3%) |
| Mar 2022 | $68.23 M(+11.6%) | $68.23 M(+56.2%) |
| Dec 2021 | - | $43.69 M(-20.9%) |
| Sept 2021 | - | $55.23 M(-11.0%) |
| June 2021 | - | $62.07 M(+1.5%) |
| Mar 2021 | $61.17 M(+112.0%) | $61.17 M(+34.7%) |
| Dec 2020 | - | $45.41 M(+13.6%) |
| Sept 2020 | - | $39.97 M(+10.1%) |
| June 2020 | - | $36.30 M(+25.8%) |
| Mar 2020 | $28.86 M(-17.7%) | $28.86 M(-22.1%) |
| Dec 2019 | - | $37.03 M(-3.6%) |
| Sept 2019 | - | $38.41 M(+3.2%) |
| June 2019 | - | $37.21 M(+6.1%) |
| Mar 2019 | $35.06 M(+36.4%) | $35.06 M(+7.9%) |
| Dec 2018 | - | $32.50 M(+7.6%) |
| Sept 2018 | - | $30.21 M(+13.9%) |
| June 2018 | - | $26.51 M(+3.2%) |
| Mar 2018 | $25.70 M(+56.7%) | $25.70 M(+7.6%) |
| Dec 2017 | - | $23.89 M(-88.1%) |
| Sept 2017 | - | $201.55 M(-2.1%) |
| June 2017 | - | $205.77 M(+1155.1%) |
| Mar 2017 | $16.39 M(-13.0%) | $16.39 M(-93.2%) |
| Dec 2016 | - | $239.46 M(+6.0%) |
| Sept 2016 | - | $225.97 M(-7.2%) |
| June 2016 | - | $243.38 M(+1190.9%) |
| Mar 2016 | $18.85 M(-3.2%) | $18.85 M(-93.5%) |
| Dec 2015 | - | $290.42 M(+5.6%) |
| Sept 2015 | - | $275.03 M(+10.9%) |
| June 2015 | - | $248.08 M(+1173.5%) |
| Mar 2015 | $19.48 M(-6.3%) | $19.48 M(-92.7%) |
| Dec 2014 | - | $265.62 M(+19.0%) |
| Sept 2014 | - | $223.21 M(-6.3%) |
| June 2014 | - | $238.30 M(+1046.0%) |
| Mar 2014 | $20.80 M(+7.3%) | $20.80 M(-91.0%) |
| Dec 2013 | - | $231.85 M(+7.6%) |
| Sept 2013 | - | $215.51 M(+7.8%) |
| June 2013 | - | $199.97 M(+931.4%) |
| Mar 2013 | $19.39 M(-15.6%) | $19.39 M(-88.1%) |
| Dec 2012 | - | $162.76 M(+608.3%) |
| Mar 2012 | $22.98 M(-1.5%) | $22.98 M(-1.5%) |
| Dec 2011 | $23.32 M(+6.5%) | $23.32 M(-84.2%) |
| Sept 2011 | - | $147.16 M(+40.2%) |
| June 2011 | - | $105.00 M(+1.4%) |
| Mar 2011 | - | $103.53 M(+372.7%) |
| Dec 2010 | $21.91 M(-21.7%) | $21.91 M(-21.7%) |
| Dec 2009 | $27.98 M(+8.1%) | $27.98 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $25.88 M(+27.3%) | $25.88 M(-81.7%) |
| Dec 2007 | $20.33 M(+10.2%) | - |
| Dec 2006 | $18.44 M(-87.0%) | - |
| Dec 2005 | $141.32 M(+691.9%) | $141.32 M(+220.1%) |
| Sept 2005 | - | $44.15 M(-11.8%) |
| June 2005 | - | $50.04 M(-3.0%) |
| Mar 2005 | - | $51.59 M(+189.1%) |
| Dec 2004 | $17.84 M(-31.8%) | $17.84 M(-59.6%) |
| Sept 2004 | - | $44.21 M(-13.3%) |
| June 2004 | - | $50.96 M(-13.4%) |
| Mar 2004 | - | $58.87 M(+125.1%) |
| Dec 2003 | $26.15 M(+3.7%) | $26.15 M(-48.2%) |
| Sept 2003 | - | $50.45 M(-4.4%) |
| June 2003 | - | $52.76 M(-7.9%) |
| Mar 2003 | - | $57.29 M(+127.2%) |
| Dec 2002 | $25.22 M(-5.0%) | $25.22 M(-21.3%) |
| Sept 2002 | - | $32.06 M(+16.2%) |
| June 2002 | - | $27.59 M(+24.7%) |
| Mar 2002 | - | $22.12 M(-16.7%) |
| Dec 2001 | $26.55 M(+197.8%) | $26.55 M(+18.7%) |
| Sept 2001 | - | $22.37 M(+14.4%) |
| June 2001 | - | $19.56 M(+10.9%) |
| Mar 2001 | - | $17.64 M(+97.9%) |
| Dec 2000 | $8.92 M(+65.8%) | $8.92 M(-48.4%) |
| Sept 2000 | - | $17.27 M(+18.8%) |
| June 2000 | - | $14.54 M(+5.4%) |
| Mar 2000 | - | $13.79 M(+156.6%) |
| Dec 1999 | $5.38 M(-46.2%) | $5.38 M(-59.6%) |
| Sept 1999 | - | $13.30 M(-16.9%) |
| June 1999 | - | $16.00 M(+40.4%) |
| Mar 1999 | - | $11.40 M(+14.0%) |
| Dec 1998 | $10.00 M(-21.3%) | $10.00 M(-37.5%) |
| Mar 1998 | - | $16.00 M(+26.0%) |
| Dec 1997 | $12.70 M(+23.3%) | $12.70 M(-12.4%) |
| Sept 1997 | - | $14.50 M(+28.3%) |
| June 1997 | - | $11.30 M(+10.8%) |
| Mar 1997 | - | $10.20 M(-1.0%) |
| Dec 1996 | $10.30 M(+22.6%) | $10.30 M(-5.5%) |
| Sept 1996 | - | $10.90 M(+5.8%) |
| June 1996 | - | $10.30 M(+13.2%) |
| Mar 1996 | - | $9.10 M(+8.3%) |
| Dec 1995 | $8.40 M(+10.5%) | $8.40 M(+10.5%) |
| Dec 1994 | $7.60 M(+35.7%) | $7.60 M(+35.7%) |
| Dec 1993 | $5.60 M(+1.8%) | $5.60 M(+1.8%) |
| Dec 1992 | $5.50 M(+41.0%) | $5.50 M(+17.0%) |
| Sept 1992 | - | $4.70 M(+6.8%) |
| June 1992 | - | $4.40 M(-10.2%) |
| Mar 1992 | - | $4.90 M(+25.6%) |
| Dec 1991 | $3.90 M | $3.90 M(-15.2%) |
| Sept 1991 | - | $4.60 M(-2.1%) |
| June 1991 | - | $4.70 M(+23.7%) |
| Mar 1991 | - | $3.80 M(+46.2%) |
| Mar 1990 | - | $2.60 M |
FAQ
- What is Taro Pharmaceutical Industries annual accounts payable?
- What is the all time high annual accounts payable for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual accounts payable year-on-year change?
- What is Taro Pharmaceutical Industries quarterly accounts payable?
- What is the all time high quarterly accounts payable for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly accounts payable year-on-year change?
What is Taro Pharmaceutical Industries annual accounts payable?
The current annual accounts payable of TARO is $44.66 M
What is the all time high annual accounts payable for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual accounts payable is $141.32 M
What is Taro Pharmaceutical Industries annual accounts payable year-on-year change?
Over the past year, TARO annual accounts payable has changed by -$23.82 M (-34.78%)
What is Taro Pharmaceutical Industries quarterly accounts payable?
The current quarterly accounts payable of TARO is $44.66 M
What is the all time high quarterly accounts payable for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly accounts payable is $290.42 M
What is Taro Pharmaceutical Industries quarterly accounts payable year-on-year change?
Over the past year, TARO quarterly accounts payable has changed by -$6.52 M (-12.74%)